HomeBusinessHealthcare Industry Stock NewsProthena (PRTA) Rallies Along With Biogen (BIIB)

Prothena (PRTA) Rallies Along With Biogen (BIIB)

Prothena (PRTA) stock price today was up over 87%. Prothena is a late-stage clinical company engaged in the protein dysregulation. Their pipeline includes Parkinson's disease and Alzheimer's therapies. The PRTA stock was upgraded following positive data from Biogen (BIIB). George Tsilis weighs in on the BOFA analyst note that stated Prothena trial result is a big milestone in the treatment of Alzheimer's disease.

Market On Close

28 Sep 2022

SHARE

ON AIR
education
2:30 am
Your First Trade
replay
12:00 am
Fast Market
REPLAY
education
1:00 am
Your First Trade
REPLAY
1:30 am
Next Gen Investing
REPLAY
ON AIR
education
2:30 am
Your First Trade
REPLAY
3:00 am
Trading 360
REPLAY
4:00 am
Fast Market
REPLAY
5:00 am
Next Gen Investing
REPLAY
education
6:00 am
Your First Trade
REPLAY
6:30 am
Trading 360
REPLAY
7:30 am
Fast Market
REPLAY
8:30 am
Next Gen Investing
REPLAY
9:30 am
Market Overtime
REPLAY
10:00 am
Trading 360
REPLAY
11:00 am
Fast Market
REPLAY
12:00 pm
Next Gen Investing
REPLAY
education
1:00 pm
Your First Trade
REPLAY
1:30 pm
Trading 360
REPLAY
2:30 pm
Fast Market
REPLAY
3:30 pm
Next Gen Investing
REPLAY
4:30 pm
Market Overtime
REPLAY
5:00 pm
Trading 360
REPLAY
6:00 pm
Fast Market
REPLAY
7:00 pm
Next Gen Investing
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Trading 360
REPLAY
9:30 pm
Fast Market
REPLAY
10:30 pm
Next Gen Investing
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor

coming soon

We are now

coming soon

We are now